Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.26 USD | -0.75% | +5.90% | -32.03% |
Jun. 05 | Transcript : Syros Pharmaceuticals, Inc. - Shareholder/Analyst Call | |
May. 14 | Transcript : Syros Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 14, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.03% | 142M | |
+58.51% | 59.34B | |
+43.17% | 40.24B | |
-5.13% | 39.88B | |
-5.56% | 28.55B | |
+15.57% | 27.26B | |
-21.30% | 19.23B | |
+33.35% | 12.61B | |
+2.92% | 12.49B | |
+26.65% | 12.28B |
- Stock Market
- Equities
- SYRS Stock
- News Syros Pharmaceuticals, Inc.
- Syros Pharmaceuticals Appoints Deborah Dunsire to the Board of Directors